Reduction Of Dimer Content In Factor Vii Polypeptide Compositions By Heat Treatment

Patent No. EP2201111 (titled "Reduction Of Dimer Content In Factor Vii Polypeptide Compositions By Heat Treatment") was filed by Novo Nordisk Health Care on Aug 22, 2008. The application was issued on Aug 13, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BAXALTAMay 13, 2015HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2201111

NOVO NORDISK HEALTH CARE
Application Number
EP08787413A
Filing Date
Aug 22, 2008
Status
Opposition Rejected
Mar 10, 2017
Publication Date
Aug 13, 2014